SHANNON NALE: Open Payments
NPI 1881028553 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 30 payments from 15 companies in 2025. Trend: 2023 $958 · 2024 $1,500 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $213 |
| ABBVIE INC. | 6 | $108 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| Amgen Inc. | 3 | $52 |
| Viatris Specialty LLC | 1 | $29 |
| Exact Sciences Corporation | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: AIRSUPRA, VRAYLAR, BREZTRI, TRELEGY ELLIPTA, REPATHA, YUPELRI, Cologuard Collection Kit, KISUNLA.
Industry payments across IN — which companies pay providers there.
